mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug 18.
No abstract available

Keywords: COVID-19; multiple sclerosis; neuroimmunology.

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Multiple Sclerosis*
  • RNA, Messenger
  • Recurrence

Substances

  • COVID-19 Vaccines
  • RNA, Messenger